MedTrace Logo

Comparison of Intra and Extraluminal Bronchial Blocker in Adults

NCT02646813 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2018-08-13

No results posted yet for this study

Summary

The objective of this study is to evaluate the time and ease of placement of an extra-luminal Arndt bronchial blocker versus placing it intra-luminally.

An additional objective will be to assess if there are any other significant clinical differences between these two approaches to placement of the BB including overall quality of isolation, an increase in post-operatives sore throat, post-operative hoarseness, and increased incidence of needing to reposition the blocker

Conditions

  • Operative, Non Cardiac, Thoracic Disease

Interventions

PROCEDURE

Intraluminal Placement

Pt. will have Arndt Endobronchial Blocker placed intraluminally

PROCEDURE

Extraluminal Placement

Pt. will have Arndt Endobronchial Blocker placed extraluminally

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Thomas W Templeton, MD · Wake Forest University Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-08-31
Completion
2016-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02646813 on ClinicalTrials.gov